Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
BPMC
Stock Latest News
Ratings
Blueprint Medicines’ Ayvakit Poised to Maintain Market Leadership Amidst Competitive Challenges
13h ago
BPMC
Premium
Ratings
Cautious Optimism: Blueprint Medicines’ Hold Rating Amid Mixed Growth Signals
12d ago
BPMC
Premium
Ratings
Blueprint Medicines: Strong Market Position and Growth Potential Justify Buy Rating with $135 Price Target
15d ago
BPMC
Premium
Company Announcements
Blueprint Medicines Reports Strong Q1 2025 Growth
15d ago
BPMC
Premium
Company Announcements
Blueprint Medicines Corp. Reports Strong Earnings Growth
15d ago
BPMC
Premium
Ratings
Positive Outlook for Blueprint Medicines Driven by Strong Ayvakit Performance and Pipeline Progress
15d ago
BPMC
Premium
Ratings
Blueprint Medicines: Strong Financial Performance and Strategic Initiatives Justify Buy Rating
15d ago
BPMC
Premium
The Fly
Blueprint Medicines reports Q1 EPS 1c, consensus (44c)
15d ago
BPMC
Premium
Pre-Earnings
Blueprint Medicines Corp. (BPMC) Q1 Earnings Cheat Sheet
18d ago
BPMC
Premium
The Fly
Blueprint Medicines price target lowered to $130 from $133 at Needham
18d ago
BPMC
Premium
Ratings
Positive Outlook for Blueprint Medicines Amid Market Challenges: Buy Rating Affirmed
19d ago
BPMC
Premium
Ratings
Hold Rating for Blueprint Medicines Amidst Near-Term Challenges and Revenue Variability
25d ago
BPMC
Premium
Ratings
Blueprint Medicines: A Defensive Biotech with Strong Growth Potential and M&A Appeal
1M ago
BPMC
Premium
Ratings
Blueprint Medicines: Strong Growth Potential Driven by Ayvakit and Promising Pipeline
1M ago
BPMC
Premium
Ratings
Optimistic Long-Term Growth Potential for Blueprint Medicines Amid Short-Term Revenue Concerns
2M ago
BPMC
Premium
The Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
2M ago
BPMC
COGT
Premium
The Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
2M ago
BPMC
COGT
Premium
Ratings
Blueprint Medicines: Strong Growth, Strategic M&A Potential, and Promising Pipeline Drive Positive Outlook
2M ago
BPMC
Premium
The Fly
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
2M ago
BPMC
Premium
Ratings
Balanced Outlook on Blueprint Medicines: Growth Prospects and Market Dynamics
2M ago
BPMC
Premium
The Fly
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
2M ago
BPMC
Premium
The Fly
Coinbase initiated, Block upgraded: Wall Street’s top analyst calls
2M ago
BE
RL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
